A single blood sample taken at age 8, then again at 11, 14, and 18, will track how the immune system’s response to infections and allergens shifts through puberty in 1,000 children already enrolled in a long-running study. Asthma, allergies, and respiratory infections are the most common diseases across all ages, yet the immune mechanisms linking them remain poorly understood. Treatments for asthma attacks have barely improved in 50 years. The project aims to map these mechanisms by exposing immune cells from the same children at different ages to viruses, bacteria, and allergens, and measuring the resulting responses alongside changes in gene sequences and antibody production. If successful, the research could identify new molecular targets for drugs that prevent asthma development or block asthma attacks. It may also explain why boys are more vulnerable before puberty and girls after, potentially leading to age- or sex-specific treatments. Because the work is fundamental science—using novel computational methods to understand complex immune interactions—immediate clinical applications are not guaranteed. But similar systems-level approaches have previously uncovered unexpected drug targets in other chronic inflammatory diseases.
View original technical description
Asthma, allergies and respiratory tract infections (RTIs) are the most common diseases in childhood and adulthood. Although they are inextricably linked, the immune mechanisms governing the relationships between the infection, allergy and increased risk of asthma development and asthma attacks are very poorly understood. Consequently, there have been few advances in treatments for asthma (and in particular asthma attacks) in the last 50 years. Severity and risk of these conditions varies substantially with age, with in particular large changes occurring through puberty - before puberty boys have increased risk/severity of asthma and RTIs, while after puberty females are at substantially greater risk. Impaired immune responses to viruses are strongly implicated in increased susceptibility to virus infections in asthma, but the mechanisms behind these impaired responses are unknown. The mechanisms explaining increased susceptibility to bacterial infections in asthma are unknown. We propose a novel approach aiming to understand the mechanisms of interplay between asthma, allergies and innate immune responses to viruses and bacteria. Building on knowledge we already have of a population of 1000 children, followed since birth to look for risk factors for asthma and allergies, we will collect new data (outlined below) and by using a systems approach to apply innovative computational statistical methods to the data we will study the interactions between host response to infections, allergens and asthma. This will give a better understanding of why children develop asthma, how this changes through puberty and we hope to identify new targets for possible drug therapies. We will combine world-leading expertise in birth cohort/life course studies, respiratory infections, innate immunity, asthma and allergies and computational analysis We will utilise novel analytical techniques to identify mechanisms related to increased susceptibility to RTIs causing increased susceptibility to asthma development and asthma attacks We will investigate changes in the way the body handles infection from bacteria and viruses from childhood by taking blood cells from the body at age 8 years, through puberty (ages 11 & 14), to adulthood (age 18) and exposing them to these infectious agents and measuring the response We will investigate how through puberty the body changes in the way it makes antibodies to allergens, by measuring IgE antibodies at the time points above We will investigate how changes in gene sequences are associated with immunity to infection and to allergens. We will analyse the data using novel computational techniques, recognising that these systems are highly complex and interact with each other, and do not operate in isolation By studying mechanisms which are important regulators at a molecular level, we will identify potential targets for treatment or prevention of asthma development, asthma attacks and RTIs. Potential therapeutic targets will be validated using molecular cell biology techniques in human primary cells and in vivo studies in which the applicants are well versed.
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know